Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Angina Pectoris: full-pipeline trial registry
1 of 10 indexed Angina Pectoris trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 1 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Angina Pectoris: 10 US clinical trials tracked, 1 recruiting.
Angina Pectoris is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is CardioDx, running 2 of these trials.
Enrollment posture brief
Registry condition angina-pectoris
OPEN 1 | RECR 10% | LATE 2 | EARLY 2 | RANK #1724 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Cancer of Head and Neck (10% recruiting · 10 trials)
Angina Pectoris lists 1 open slots (10% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Angina Pectoris on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Angina Pectoris is recruiting below its size-band peers.
1 of 10 indexed trials (10%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Angina Pectoris research.
CardioDx accounts for 2 of 10 trials (20%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Angina Pectoris enrolment sits around 400 participants.
Median target enrolment is 400 among the 10 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Angina Pectoris research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Stanford University
NCT06424834
Invest-CTO PCI Trial
Haukeland University Hospital
NCT04774913
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
CardioDx
NCT00500617
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
Tasly Pharmaceuticals
NCT01659580
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Gilead Sciences
NCT01425359
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
CardioDx
NCT01117506
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
Montefiore Medical Center
NCT01384448
Collaborative Cardiac Care Project
US Department of Veterans Affairs
NCT00105664
Comparing TR Band to Statseal in Conjunction With TR Band
VA Long Beach Healthcare System
NCT03028025
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
Tasly Pharmaceuticals
NCT00797953
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Angina Pectoris records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Angina Pectoris trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Angina Pectoris page
10 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Angina Pectoris trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- CardioDx sponsors the most Angina Pectoris trials on record, review their full trial history before evaluating a specific study. See CardioDx's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Angina Pectoris condition card totals 10 registered trials; most-linked intervention Corus CAD (ASGES); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.